LK
SBC

Lumbard & Kellner’s SBC Medical Group SBC Stock Holding History

Lumbard & Kellner’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.2K Buy
+17,273
New +$72.1K 0.03% 99

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lumbard & Kellner's SBC Position: Q1 2026 in Review

Lumbard & Kellner opened a new position in SBC Medical Group (SBC) in Q1 2026: 17,273 shares worth $72.2K. The stake represents 0.03% of the portfolio and ranks #99 among its holdings.

50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Lumbard & Kellner held 17,273 shares of SBC Medical Group worth $72.2K as of Q1 2026.
  • SBC Medical Group was a new Lumbard & Kellner position in Q1 2026.
  • SBC Medical Group made up 0.03% of Lumbard & Kellner's portfolio in Q1 2026, its #99 holding.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Lumbard & Kellner's 13F filing for Q1 2026, filed 15 May 2026.